2667-0054

Journal of the National Cancer Center

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 295 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact295 DOIs
2

Attach ORCID iDs across 91 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact91 DOIs
3

Deposit reference lists for 32 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact32 DOIs

DOIs for this ISSN

Showing the top 5 of 295 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Cancer cell mechanobiology: a new frontier for cancer resear… (10.1016/j.jncc.2021.11.007)
Abstract ORCID
83.14 45
2 Cancer incidence and mortality in China, 2022 (10.1016/j.jncc.2024.01.006)
Abstract
80.42 1646
3 Lung cancer incidence and mortality in China: Updated statis… (10.1016/j.jncc.2022.07.004)
Abstract ORCID
80.10 39
4 Cancer incidence and mortality in China, 2016 (10.1016/j.jncc.2022.02.002)
Abstract
76.51 1148
5 Targeting HER2 genomic alterations in non-small cell lung ca… (10.1016/j.jncc.2021.04.001)
Abstract ORCID
72.36 27
6 Immunotherapy in breast cancer: A clinician's perspective (10.1016/j.jncc.2021.01.001)
Abstract ORCID
69.01 23
7 Intelligent oncology: The convergence of artificial intellig… (10.1016/j.jncc.2022.11.004)
Abstract ORCID
69.01 23
8 Benefits and harms of screening for hepatocellular carcinoma… (10.1016/j.jncc.2023.02.001)
Abstract ORCID
65.05 19
9 Psychological distress and quality of life in Chinese early-… (10.1016/j.jncc.2022.06.002)
Abstract ORCID
63.94 18
10 Risk factors for early-onset colorectal cancer: A large-scal… (10.1016/j.jncc.2023.01.001)
Abstract ORCID
61.52 16
11 Cancer incidence and mortality in China, 2015 (10.1016/j.jncc.2020.12.001)
Abstract
61.41 285
12 Overcoming cancer treatment resistance: Unraveling the role… (10.1016/j.jncc.2025.03.002)
Abstract ORCID
58.80 14
13 Guidelines for diagnosis and treatment of advanced breast ca… (10.1016/j.jncc.2023.12.001)
Abstract ORCID
57.31 13
14 Night shift work and breast cancer risk – 2023 update of epi… (10.1016/j.jncc.2024.07.004)
Abstract ORCID
57.31 13
15 Interpretation of specification for breast cancer screening,… (10.1016/j.jncc.2021.07.003)
Abstract ORCID
55.70 12
16 Prospect of radiotherapy technology development in the era o… (10.1016/j.jncc.2022.04.001)
Abstract ORCID
53.96 11
17 Comparative study of cancer profiles between 2020 and 2022 u… (10.1016/j.jncc.2024.05.001)
Abstract
51.13 110
18 Global burden of female breast cancer: new estimates in 2022… (10.1016/j.jncc.2025.02.002)
Abstract
51.13 110
19 Cancer survival statistics in China 2019–2021: a multicenter… (10.1016/j.jncc.2024.06.005)
Abstract
50.73 106
20 The roles of histone modifications in tumorigenesis and asso… (10.1016/j.jncc.2022.09.002)
Abstract
50.43 103
21 Pyrotinib in HER2 heterogeneously mutated or amplified advan… (10.1016/j.jncc.2021.08.001)
Abstract ORCID
50.00 9
22 Spatial and maturity heterogeneity of tertiary lymphoid stru… (10.1016/j.jncc.2025.06.003)
Abstract ORCID
50.00 9
23 Patterns and trends in esophageal cancer incidence and morta… (10.1016/j.jncc.2023.01.002)
Abstract
48.24 84
24 Global burden of cervical cancer: current estimates, tempora… (10.1016/j.jncc.2024.11.006)
Abstract
48.11 83
25 Cancer screening in the aging population: Where do we stand… (10.1016/j.jncc.2022.08.001)
Abstract ORCID
47.71 8
26 Minimally invasive versus open esophagectomy for resectable… (10.1016/j.jncc.2023.02.002)
Abstract ORCID
47.71 8
27 Dynamic bTMB combined with residual ctDNA improves survival… (10.1016/j.jncc.2024.01.008)
Abstract ORCID
47.71 8
28 Global, regional, and national burden of genitourinary cance… (10.1016/j.jncc.2025.03.001)
Abstract ORCID
47.71 8
29 Nowcasting and forecasting global aging and cancer burden: a… (10.1016/j.jncc.2024.05.002)
Abstract
45.81 67
30 Lung cancer risk in non-smoking females with a familial hist… (10.1016/j.jncc.2021.07.002)
Abstract ORCID
45.15 7
31 Methodological advances in necroptosis research: From challe… (10.1016/j.jncc.2022.08.007)
Abstract ORCID
45.15 7
32 Patient-derived organoids (PDOs) and PDO-derived xenografts… (10.1016/j.jncc.2022.10.001)
Abstract
41.57 45
33 Etiology of lung cancer: Evidence from epidemiologic studies (10.1016/j.jncc.2022.09.004)
Abstract
41.09 43
34 Cancer overdiagnosis: A challenge in the era of screening (10.1016/j.jncc.2022.08.005)
Abstract
40.84 42
35 Head-to-head comparison of 7 high-sensitive human papillomav… (10.1016/j.jncc.2022.06.003)
Abstract ORCID
38.91 5
36 Treatments of transarterial chemoembolization (TACE), stereo… (10.1016/j.jncc.2024.06.007)
Abstract ORCID
38.91 5
37 Immunotherapy for triple-negative breast cancer: A molecular… (10.1016/j.jncc.2021.06.001)
Abstract
38.60 34
38 The epidemiological landscape of lung cancer: current status… (10.1016/j.jncc.2025.01.003)
Abstract
38.60 34
39 Incidence and mortality of cervical cancer in China in 2015 (10.1016/j.jncc.2022.01.002)
Abstract
36.56 28
40 The potential role of minimal/molecular residual disease in… (10.1016/j.jncc.2023.05.005)
Abstract ORCID
34.95 4
41 Prostate cancer in China: epidemiological trends, genomic in… (10.1016/j.jncc.2025.05.002)
Abstract ORCID
34.95 4
42 Transcriptional and epigenetic reprogramming, lineage plasti… (10.1016/j.jncc.2025.06.001)
Abstract ORCID
34.95 4
43 Characteristics of tumor microenvironment and novel immunoth… (10.1016/j.jncc.2022.10.002)
Abstract
34.04 22
44 Chinese Society of Clinical Oncology (CSCO): Clinical guidel… (10.1016/j.jncc.2022.08.006)
Abstract
33.56 21
45 Towards automated organs at risk and target volumes contouri… (10.1016/j.jncc.2022.09.003)
Abstract
33.56 21
46 Etiology of non-Hodgkin lymphoma: A review from epidemiologi… (10.1016/j.jncc.2022.08.003)
Abstract
33.06 20
47 Assessment of the expression pattern of HER2 and its correla… (10.1016/j.jncc.2023.02.003)
Abstract
32.53 19
48 Quality of life and survival outcomes of patients with inope… (10.1016/j.jncc.2023.05.001)
Abstract
31.97 18
49 Understanding the role of endothelial cells in brain tumor f… (10.1016/j.jncc.2023.08.001)
Abstract
31.97 18
50 Therapy-induced senescent tumor cells in cancer relapse (10.1016/j.jncc.2023.09.001)
Abstract
31.97 18